Eva Lesén

531 total citations
43 papers, 356 citations indexed

About

Eva Lesén is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Eva Lesén has authored 43 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Economics and Econometrics. Recurrent topics in Eva Lesén's work include Potassium and Related Disorders (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Eva Lesén is often cited by papers focused on Potassium and Related Disorders (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Pharmaceutical Practices and Patient Outcomes (6 papers). Eva Lesén collaborates with scholars based in Sweden, United Kingdom and United States. Eva Lesén's co-authors include Karolina Andersson Sundell, Anders Carlsten, Ingela Björholt, Max Petzold, Anna K. Jönsson, Ann‐Charlotte Mårdby, Aude Houchard, Daniel Granfeldt, Jérôme Dinet and Daniel S Olsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Eva Lesén

39 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Lesén Sweden	12	95	69	65	62	55	43	356
Michele Tari Italy	13	59 0.6×	54 0.8×	73 1.1×	66 1.1×	20 0.4×	26	615
Shuo‐Chun Weng Taiwan	12	62 0.7×	39 0.6×	48 0.7×	21 0.3×	68 1.2×	45	428
Matteo Monzio Compagnoni Italy	10	76 0.8×	24 0.3×	36 0.6×	33 0.5×	34 0.6×	31	313
Wojciech Tański Poland	13	47 0.5×	63 0.9×	23 0.4×	22 0.4×	73 1.3×	39	467
Amie T. Joyce United States	15	65 0.7×	82 1.2×	30 0.5×	139 2.2×	39 0.7×	17	512
Augustine Lam Hong Kong	9	70 0.7×	46 0.7×	37 0.6×	19 0.3×	42 0.8×	17	366
Roma Puronaitė Lithuania	12	190 2.0×	39 0.6×	67 1.0×	33 0.5×	92 1.7×	52	415
Iefke Drion Netherlands	12	84 0.9×	145 2.1×	71 1.1×	22 0.4×	55 1.0×	17	414
Ronald D. Scott United States	12	204 2.1×	89 1.3×	37 0.6×	165 2.7×	39 0.7×	24	550
Valeria Vietto Argentina	12	37 0.4×	57 0.8×	51 0.8×	66 1.1×	52 0.9×	26	604

Countries citing papers authored by Eva Lesén

Since Specialization

Citations

This map shows the geographic impact of Eva Lesén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Lesén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Lesén more than expected).

Fields of papers citing papers by Eva Lesén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Lesén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Lesén. The network helps show where Eva Lesén may publish in the future.

Co-authorship network of co-authors of Eva Lesén

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Lesén. A scholar is included among the top collaborators of Eva Lesén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Lesén. Eva Lesén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Svensson, Maria, Michael Fischereder, Paul R. Kalra, et al.. (2024). Estimated Number Needed to Treat to Avoid a First Hospitalization by Maintaining Instead of Reducing Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Therapy after Hyperkalemia. Kidney360. 5(12). 1813–1823.

Burton, James O., Alpesh Amin, Cecilia Linde, et al.. (2023). Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidney disease. Clinical Kidney Journal. 16(7). 1160–1169. 2 indexed citations

Svensson, Maria, et al.. (2023). EE268 Healthcare Costs and All-Cause Mortality Following a Hyperkalemia Event and Reduction of RAASi Therapy in Sweden. Value in Health. 26(12). S103–S103. 1 indexed citations

Kanda, Eiichiro, Anjay Rastogi, Toyoaki Murohara, et al.. (2023). Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrology. 24(1). 18–18. 26 indexed citations

Dobesh, Paul P., Gregory J. Fermann, Mary J. Christoph, et al.. (2023). Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study. Research and Practice in Thrombosis and Haemostasis. 7(6). 102192–102192. 17 indexed citations

Kanda, Eiichiro, Charles V. Pollack, Anjay Rastogi, et al.. (2023). #3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

Lesén, Eva, et al.. (2020). Age in relation to comorbidity and outcome in patients with high-risk TIA or minor ischemic stroke: A Swedish national observational study. European Stroke Journal. 6(1). 53–61. 3 indexed citations

Kaufman, Brystana G., Shreyansh Shah, Anne S. Hellkamp, et al.. (2020). Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. Journal of Stroke and Cerebrovascular Diseases. 29(12). 105399–105399. 11 indexed citations

Lesén, Eva, Daniel Granfeldt, Aude Houchard, et al.. (2019). Treatment Patterns and Survival among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumours in Sweden - a Population-based Register-linkage and Medical Chart Review Study. Journal of Cancer. 10(27). 6876–6887. 8 indexed citations

10.

Lesén, Eva, Ingela Björholt, Anders Ingelgård, & Fredrik J. Olson. (2017). EXPLORATION AND PREFERENTIAL RANKING OF PATIENT BENEFITS OF MEDICAL DEVICES: A NEW AND GENERIC INSTRUMENT FOR HEALTH ECONOMIC ASSESSMENTS. International Journal of Technology Assessment in Health Care. 33(4). 463–471. 13 indexed citations

11.

Björstad, Åse, Thomas Marlow, Eva Lesén, et al.. (2017). Real-World Resource Use And Costs of Carcinoid Heart Disease In Patients With Neuroendocrine Tumors: A Retrospective Swedish Study. Value in Health. 20(9). A552–A552. 1 indexed citations

12.

Lesén, Eva, Daniel Granfeldt, Aude Houchard, et al.. (2017). Overall survival in patients diagnosed with metastatic GEP-NET in Sweden. Annals of Oncology. 28. iii4–iii4. 1 indexed citations

13.

Lesén, Eva, Daniel Granfeldt, Aude Houchard, et al.. (2016). Cost-of-Illness of Acromegaly in Sweden – A Register-Linkage Population-Based Study. Value in Health. 19(7). A669–A669. 2 indexed citations

14.

Mårdby, Ann‐Charlotte, et al.. (2016). Adherence to antidepressants among women and men described with trajectory models: a Swedish longitudinal study. European Journal of Clinical Pharmacology. 72(11). 1381–1389. 12 indexed citations

15.

Jönsson, Anna K., et al.. (2016). Refill Adherence in Relation to Substitution and the Use of Multiple Medications: A Nationwide Population Based Study on New ACE-Inhibitor Users. PLoS ONE. 11(5). e0155465–e0155465. 1 indexed citations

16.

Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2014). Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation. Thrombosis Research. 133(6). 1061–1067. 4 indexed citations

17.

Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2013). Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation. Value in Health. 16(7). A328–A328. 1 indexed citations

18.

Lesén, Eva, Karolina Andersson Sundell, A. Carlsten, Ann‐Charlotte Mårdby, & Anna K. Jönsson. (2013). Is the level of patient co-payment for medicines associated with refill adherence in Sweden?. European Journal of Public Health. 24(1). 85–90. 18 indexed citations

19.

Lesén, Eva, Anders Carlsten, Ingmar Skoog, et al.. (2011). Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. International Psychogeriatrics. 23(8). 1270–1277. 5 indexed citations

20.

Wallander, Mari‐Ann, et al.. (2009). Aspirin in cardiology - benefits and risks. International Journal of Clinical Practice. 63(3). 468–477. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact